Short interest in BridgeBio Pharma Inc (NASDAQ:BBIO) decreased during the last reporting period, falling from 17.19M to 17.00M. This put 13.81% of the company's publicly available shares short.

Short interest for BridgeBio Pharma gives investors a sense of the degree to which investors are betting on the decline of BridgeBio Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 3.63M shares traded per day, it would take 4.68 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.